<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39446732</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>10</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>A multi-site cross-sectional study on the burden of SARS-CoV-2 in healthcare workers in Madagascar.</ArticleTitle><Pagination><StartPage>e0309977</StartPage><MedlinePgn>e0309977</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0309977</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0309977</ELocationID><Abstract><AbstractText>The prevalence of infections and risk factors that go along with them give insights into the burden of disease and effectiveness of infection prevention and control strategies. In this study we investigated the burden of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and associated epidemiological factors in three regions of Madagascar among healthcare workers. Between May and June 2021, we conducted a multi-site cross-sectional study among healthcare workers in eight University Hospital Centers, during the local second wave and before the coronavirus disease 2019 vaccination campaign in three regional capitals of Madagascar. We collected demographic information and relevant SARS-CoV-2 exposure history and tested for both immunoglobulin G antibodies to SARS-CoV-2 spike protein, using enzyme-linked immunosorbent assay and active SARS-CoV-2 infection using real-time reverse transcription-polymerase chain reaction. A total of 1006 healthcare workers enrolled in the study out of which 53.8% tested positive for either acute infection or SARS-CoV-2 antibodies. Approximately 50% of the participants reported receiving inadequate training on SARS-CoV-2 and associated infection prevention and control measures, inadequate supply of Personal Protective Equipment (PPE) and discomfort when using available PPE. Prevalence of acute infection was 3.4% without statistically significant variation in the different regions or health facilities as well as the different profession groups and units of work. Average seroprevalence of SARS-CoV-2 IgG antibodies was 52.0%, varying between 47.8% and 53.3% across the different regions. No significant difference was observed for region, gender, profession, and different risk groups. Predictive multivariable model showed significant association between seropositivity and healthcare facility and age (p&lt;0.05). Our results revealed high infection rate of SARS-CoV-2 in HCWs in all three selected regions of Madagascar. The high disease burden identified in the study population might characterize the extent of high undocumented infection rates in HCWs in other regions of Madagascar.</AbstractText><CopyrightInformation>Copyright: © 2024 Abrokwa et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abrokwa</LastName><ForeName>Seth Kofi</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Center for International Health Protection, Robert Koch Institute, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ravaoarisoa</LastName><ForeName>Lantonirina</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Laboratoire d'Analyses Médicales Malagasy, Antananarivo, Madagascar.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut National de Santé Publique et Communautaire-Madagascar, Antananarivo, Madagascar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briesemeister</LastName><ForeName>Veronica</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Center for International Health Protection, Robert Koch Institute, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrianasolo</LastName><ForeName>Radonirina Lazasoa</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Faculté de Médecine, Université d'Antananarivo, Antananarivo, Madagascar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrianarivelo</LastName><ForeName>Andry Maharo</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Laboratoire d'Analyses Médicales Malagasy, Antananarivo, Madagascar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Müller</LastName><ForeName>Sophie Alice</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Center for International Health Protection, Robert Koch Institute, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Randriamanantany</LastName><ForeName>Zely Arivelo</ForeName><Initials>ZA</Initials><AffiliationInfo><Affiliation>Laboratoire d'Analyses Médicales Malagasy, Antananarivo, Madagascar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernasconi</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1299-7114</Identifier><AffiliationInfo><Affiliation>Center for International Health Protection, Robert Koch Institute, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiss</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4835-3695</Identifier><AffiliationInfo><Affiliation>Center for International Health Protection, Robert Koch Institute, Berlin, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008270" MajorTopicYN="N" Type="Geographic">Madagascar</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006282" MajorTopicYN="Y">Health Personnel</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="Y">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>7</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>7</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>13</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39446732</ArticleId><ArticleId IdType="pmc">PMC11500896</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0309977</ArticleId><ArticleId IdType="pii">PONE-D-24-01250</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nguyen LH, Drew DA, Graham MS, Joshi AD, Guo C-G, Ma W, et al.. Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. The Lancet Public Health. 2020;5(9):e475–e83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491202</ArticleId><ArticleId IdType="pubmed">32745512</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. The impact of COVID-19 on health and care workers: a closer look at deaths. World Health Organization, 2021.</Citation></Reference><Reference><Citation>Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet. 2020;395(10231):1225–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102589</ArticleId><ArticleId IdType="pubmed">32178769</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbeek JH, Rajamaki B, Ijaz S, Sauni R, Toomey E, Blackwood B, et al.. Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff. Cochrane Database Syst Rev. 2020;5(5):CD011621. doi: 10.1002/14651858.CD011621.pub5</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD011621.pub5</ArticleId><ArticleId IdType="pmc">PMC8785899</ArticleId><ArticleId IdType="pubmed">32412096</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Health workers exposure risk assessment and management in the context of COVID-19 virus: interim guidance, 4 March 2020. World Health Organization, 2020.</Citation></Reference><Reference><Citation>Billings J, Ching BCF, Gkofa V, Greene T, Bloomfield M. Experiences of frontline healthcare workers and their views about support during COVID-19 and previous pandemics: a systematic review and qualitative meta-synthesis. BMC Health Services Research. 2021;21(1):923. doi: 10.1186/s12913-021-06917-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-021-06917-z</ArticleId><ArticleId IdType="pmc">PMC8419805</ArticleId><ArticleId IdType="pubmed">34488733</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamdan A, Eastaugh JJ, Snygg J, Naidu J, Alhaj I. Coping strategies used by healthcare professionals during COVID-19 pandemic in Dubai: A descriptive cross-sectional study. Narra X. 2023;1(1:e71). doi: 10.52225/narrax.v1i1.71</Citation><ArticleIdList><ArticleId IdType="doi">10.52225/narrax.v1i1.71</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakotonanahary RJL, Andriambolamanana H, Razafinjato B, Raza-Fanomezanjanahary EM, Ramanandraitsiory V, Ralaivavikoa F, et al.. Integrating Health Systems and Science to Respond to COVID-19 in a Model District of Rural Madagascar. Frontiers in Public Health. 2021;9. doi: 10.3389/fpubh.2021.654299</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.654299</ArticleId><ArticleId IdType="pmc">PMC8333873</ArticleId><ArticleId IdType="pubmed">34368043</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert M, Pullano G, Pinotti F, Valdano E, Poletto C, Boelle PY, et al.. Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study. Lancet. 2020;395(10227):871–7. Epub 2020022 doi: 10.1016/S0140-6736(20)30411-6 0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30411-6</ArticleId><ArticleId IdType="pmc">PMC7159277</ArticleId><ArticleId IdType="pubmed">32087820</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Madagascar COVID-19 Situation Report
April
2021.  [14.02.2022]. Available from: https://www.unicef.org/documents/madagascar-covid-19-situation-report-april-2021.</Citation></Reference><Reference><Citation>World Health Organization. WHO Coronavirus (COVID-19) Dashboard
2022.  [cited 2022]. Available from: https://covid19.who.int/table.</Citation></Reference><Reference><Citation>World Health Organization. Madagascar Situation
2022.  [cited 2022]. Available from: https://covid19.who.int/region/afro/country/mg.</Citation></Reference><Reference><Citation>Randremanana RV, Andriamandimby S-F, Rakotondramanga JM, Razanajatovo NH, Mangahasimbola RT, Randriambolamanantsoa TH, et al.. The COVID-19 epidemic in Madagascar: clinical description and laboratory results of the first wave, march-september 2020. Influenza Other Respir Viruses. 2021;15(4):457–68. Epub 2021/02/15. doi: 10.1111/irv.12845</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12845</ArticleId><ArticleId IdType="pmc">PMC8013501</ArticleId><ArticleId IdType="pubmed">33586912</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al.. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. International journal of surgery. 2014;12(12):1495–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Health worker safety: a priority for patient safety
2022.  [cited 2022 30 May 2022]. Available from: https://www.who.int/publications/i/item/9789240011595.</Citation></Reference><Reference><Citation>Dauenhauer P, Shields M, Sloughter JM, Stewart A, Lacrampe C, Magness E, et al.., editors. Improving Shoestring Surveys for Off-Grid Humanitarian Power Projects: Kilowatts for Humanity and KoboCollect. 2018 IEEE Global Humanitarian Technology Conference (GHTC); 2018 18–21 Oct. 2018.</Citation></Reference><Reference><Citation>World Health Organization. Protocol for assessment of potential risk factors for 2019-novel coronavirus (COVID-19) infection among health care workers in a health care setting
2020. Available from: https://www.who.int/publications/i/item/protocol-for-assessment-of-potential-risk-factors-for-2019-novel-coronavirus-(2019-ncov)-infection-among-health-care-workers-in-a-health-care-setting.</Citation></Reference><Reference><Citation>Andriamandimby SF, Brook CE, Razanajatovo N, Randriambolamanantsoa TH, Rakotondramanga J-M, Rasambainarivo F, et al.. Cross-sectional cycle threshold values reflect epidemic dynamics of COVID-19 in Madagascar. Epidemics. 2022;38:100533. 10.1016/j.epidem.2021.100533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.epidem.2021.100533</ArticleId><ArticleId IdType="pmc">PMC8628610</ArticleId><ArticleId IdType="pubmed">34896895</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayı İ, Madran B, Keske Ş, Karanfil Ö, Arribas JR, Psheniсhnaya N, et al.. The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis. Clin Microbiol Infect. 2021;27(9):1242–9. Epub 2021/06/08. doi: 10.1016/j.cmi.2021.05.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.05.036</ArticleId><ArticleId IdType="pmc">PMC8186944</ArticleId><ArticleId IdType="pubmed">34116205</ArticleId></ArticleIdList></Reference><Reference><Citation>Galanis P, Vraka I, Fragkou D, Bilali A, Kaitelidou D. Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis. J Hosp Infect. 2021;108:120–34. Epub 2020/11/16. doi: 10.1016/j.jhin.2020.11.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhin.2020.11.008</ArticleId><ArticleId IdType="pmc">PMC7668234</ArticleId><ArticleId IdType="pubmed">33212126</ArticleId></ArticleIdList></Reference><Reference><Citation>Haq I, Qurieshi MA, Khan MS, Majid S, Bhat AA, Kousar R, et al.. The burden of SARS-CoV-2 among healthcare workers across 16 hospitals of Kashmir, India-A seroepidemiological study. PLoS One. 2021;16(11):e0259893. Epub 20211119. doi: 10.1371/journal.pone.0259893 ; PubMed Central PMCID: PMC8604293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0259893</ArticleId><ArticleId IdType="pmc">PMC8604293</ArticleId><ArticleId IdType="pubmed">34797880</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan MS, Haq I, Qurieshi MA, Majid S, Bhat AA, Qazi TB, et al.. SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India. J Hosp Med. 2021;16(5):274–81. doi: 10.12788/jhm.3609 .</Citation><ArticleIdList><ArticleId IdType="doi">10.12788/jhm.3609</ArticleId><ArticleId IdType="pubmed">33929947</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratovoson R, Raberahona M, Razafimahatratra R, Randriamanantsoa L, Andriamasy EH, Herindrainy P, et al.. SARS-CoV-2 infection rate in Antananarivo frontline health care workers, Madagascar. Influenza Other Respir Viruses. 2022;16(6):994–1003. Epub 2022/06/28. doi: 10.1111/irv.13022</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.13022</ArticleId><ArticleId IdType="pmc">PMC9350202</ArticleId><ArticleId IdType="pubmed">35754109</ArticleId></ArticleIdList></Reference><Reference><Citation>Müller SA, Wood RR, Hanefeld J, El-Bcheraoui C. Seroprevalence and risk factors of COVID-19 in healthcare workers from 11 African countries: a scoping review and appraisal of existing evidence. Health Policy and Planning. 2021. doi: 10.1093/heapol/czab133</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/heapol/czab133</ArticleId><ArticleId IdType="pmc">PMC8689910</ArticleId><ArticleId IdType="pubmed">34726740</ArticleId></ArticleIdList></Reference><Reference><Citation>Malagón-Rojas JN, Mercado-Reyes M, Toloza-Pérez YG, Parra Barrera EL, Palma M, Muñoz E, et al.. Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities. Occupational and Environmental Medicine. 2021:oemed-2021-107487. doi: 10.1136/oemed-2021-107487</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/oemed-2021-107487</ArticleId><ArticleId IdType="pmc">PMC8577941</ArticleId><ArticleId IdType="pubmed">34740981</ArticleId></ArticleIdList></Reference><Reference><Citation>Correia RF, da Costa ACC, Moore DCBC, de Oliveira MPC, Zuma MCC, Galvani RG et al.. SARS-CoV-2 seroprevalence and social inequalities in different subgroups of healthcare workers in Rio de Janeiro, Brazil. The Lancet Regional Health-Americas. 2022;7:100170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8718903</ArticleId><ArticleId IdType="pubmed">35005692</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant JJ, Wilmore SMS, McCann NS, Donnelly O, Lai RWL, Kinsella MJ, et al.. Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS Trust. Infection Control &amp; Hospital Epidemiology. 2021;42(2):212–4. Epub 2020/08/04. doi: 10.1017/ice.2020.402</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ice.2020.402</ArticleId><ArticleId IdType="pmc">PMC7438618</ArticleId><ArticleId IdType="pubmed">32746953</ArticleId></ArticleIdList></Reference><Reference><Citation>Isabel Galán M, Velasco M, Luisa Casas M, José Goyanes M, Rodríguez-Caravaca G, Emilio Losa J, et al.. SARS-CoV-2 Seroprevalence Among All Workers in a Teaching Hospital in Spain: Unmasking The Risk. medRxiv. 2020:2020.05.29.20116731. doi: 10.1101/2020.05.29.20116731</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.29.20116731</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoenhals M, Rabenindrina N, Rakotondramanga JM, Dussart P, Randremanana R, Heraud J-M, et al.. SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic. EBioMedicine. 2021;68:103419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8176015</ArticleId><ArticleId IdType="pubmed">34098337</ArticleId></ArticleIdList></Reference><Reference><Citation>Razafimahatratra SL, Ndiaye MDB, Rasoloharimanana LT, Dussart P, Sahondranirina PH, Randriamanantany ZA, et al.. Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors. The Lancet Global Health. 2021;9(10):e1363–e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8439619</ArticleId><ArticleId IdType="pubmed">34534478</ArticleId></ArticleIdList></Reference><Reference><Citation>Etyang AO, Lucinde R, Karanja H, Kalu C, Mugo D, Nyagwange J, et al.. Seroprevalence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers in Kenya. Clin Infect Dis. 2022;74(2):288–93. Epub 2021/04/25. doi: 10.1093/cid/ciab346</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab346</ArticleId><ArticleId IdType="pmc">PMC8135298</ArticleId><ArticleId IdType="pubmed">33893491</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhi S, Irving LB, Buising KL. COVID-19 in Australian health care workers: early experience of the Royal Melbourne Hospital emphasises the importance of community acquisition. Med J Aust. 2020;213(1):44–.e1. Epub 2020/06/11. doi: 10.5694/mja2.50664 .</Citation><ArticleIdList><ArticleId IdType="doi">10.5694/mja2.50664</ArticleId><ArticleId IdType="pmc">PMC7307019</ArticleId><ArticleId IdType="pubmed">32524609</ArticleId></ArticleIdList></Reference><Reference><Citation>Steensels D, Oris E, Coninx L, Nuyens D, Delforge M-L, Vermeersch P, et al.. Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium. JAMA. 2020;324(2):195–7. doi: 10.1001/jama.2020.11160</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.11160</ArticleId><ArticleId IdType="pmc">PMC7296458</ArticleId><ArticleId IdType="pubmed">32539107</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahon DE, Peters GA, Ivers LC, Freeman EE. Global resource shortages during COVID-19: Bad news for low-income countries. PLoS Negl Trop Dis. 2020;14(7):e0008412. Epub 2020/07/07. doi: 10.1371/journal.pntd.0008412</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0008412</ArticleId><ArticleId IdType="pmc">PMC7337278</ArticleId><ArticleId IdType="pubmed">32628664</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MC, Marshall SD. Can gendered personal protective equipment design account for high infection rates in female healthcare workers following intubation? Anaesthesia. 2021;76(1):132–3. Epub 2020/07/12. doi: 10.1111/anae.15206</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.15206</ArticleId><ArticleId IdType="pmc">PMC7405316</ArticleId><ArticleId IdType="pubmed">32654118</ArticleId></ArticleIdList></Reference><Reference><Citation>Ascott A, Crowest P, de Sausmarez E, Khan M, Chakladar A. Respiratory personal protective equipment for healthcare workers: impact of sex differences on respirator fit test results. Br J Anaesth. 2021;126(1):e48–e9. Epub 2020/10/21. doi: 10.1016/j.bja.2020.10.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.10.016</ArticleId><ArticleId IdType="pmc">PMC7577704</ArticleId><ArticleId IdType="pubmed">33183736</ArticleId></ArticleIdList></Reference><Reference><Citation>Tezcan B, Eraydin C, Karabacak BG. Protective equipment-related pressure ulcers in healthcare workers during COVID-19 pandemic: A systematic review. J Tissue Viability. 2022. Epub 2022/02/26. doi: 10.1016/j.jtv.2022.02.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtv.2022.02.004</ArticleId><ArticleId IdType="pmc">PMC8856964</ArticleId><ArticleId IdType="pubmed">35210162</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldridge RW, Lewer D, Katikireddi SV, Mathur R, Pathak N, Burns R, et al.. Black, Asian and Minority Ethnic groups in England are at increased risk of death from COVID-19: indirect standardisation of NHS mortality data. Wellcome open research. 2020;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7317462</ArticleId><ArticleId IdType="pubmed">32613083</ArticleId></ArticleIdList></Reference><Reference><Citation>Platt L, Warwick R. Are some ethnic groups more vulnerable to COVID-19 than others. the Institute for fiscal studies. 2020:2020–1.</Citation></Reference><Reference><Citation>England PH. Disparities in the Risk and Outcomes of COVID-19 (2020). Public Health England: London.</Citation></Reference><Reference><Citation>Graham LD. The right to clothing and personal protective equipment in the context of Covid-19. The International Journal of Human Rights. 2022;26(1):30–49.</Citation></Reference><Reference><Citation>Piccoli L, Ferrari P, Piumatti G, Jovic S, Rodriguez BF, Mele F, et al.. Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland. The Lancet Regional Health-Europe. 2021;1:100013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833818</ArticleId><ArticleId IdType="pubmed">34173621</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebinger JE, Botwin GJ, Albert CM, Alotaibi M, Arditi M, Berg AH, et al.. Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers: a cross-sectional study. BMJ Open. 2021;11(2):e043584. doi: 10.1136/bmjopen-2020-043584</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-043584</ArticleId><ArticleId IdType="pmc">PMC7883610</ArticleId><ArticleId IdType="pubmed">33579769</ArticleId></ArticleIdList></Reference><Reference><Citation>Naesens R, Mertes H, Clukers J, Herzog S, Brands C, Vets P, et al.. SARS-CoV-2 seroprevalence survey among health care providers in a Belgian public multiple-site hospital. Epidemiology and Infection. 2021;149:e172. Epub 2021/08/10. doi: 10.1017/S0950268821001497</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268821001497</ArticleId><ArticleId IdType="pmc">PMC8365049</ArticleId><ArticleId IdType="pubmed">34372955</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>